StreetInsider.com News Articles

BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

Tue, 25 Nov 2025 09:00:00 -0500

NEW YORK, Nov. 25, 2025 /PRNewswire/ -- BIOLASE, the global leader in dental lasers, announced its participation in the 2025 Greater New York Dental Meeting (GNYDM), taking place November 28–December 3 in New York City. As part of the program, BIOLASE will host a featured lecture led by Philip Kang, DDS, focused on advancing laser solutions for periodontal and implant health.

BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

Tue, 25 Nov 2025 09:00:00 -0500

BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

Tue, 25 Nov 2025 09:00:00 -0500

BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

Tue, 25 Nov 2025 09:00:00 -0500

BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

Tue, 25 Nov 2025 09:00:00 -0500

BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

Tue, 25 Nov 2025 09:00:00 -0500

Form SEC STAFF ACTION BIOLASE, INC

Mon, 21 Apr 2025 12:00:00 -0500

si-local-file:///var/storage/secattach/20250421/24661032.html

Form SEC STAFF ACTION BIOLASE, INC

Mon, 21 Apr 2025 12:00:00 -0500

si-local-file:///var/storage/secattach/20250421/24661032.html

Form SEC STAFF ACTION BIOLASE, INC

Mon, 21 Apr 2025 12:00:00 -0500

si-local-file:///var/storage/secattach/20250421/24661032.html

Form SC 13G/A BIOLASE, INC Filed by: Lind Global Fund II LP

Thu, 14 Nov 2024 19:20:00 -0500

si-local-file:///var/storage/secattach/20241114/23989102.html

Form SC 13G/A BIOLASE, INC Filed by: Lind Global Fund II LP

Thu, 14 Nov 2024 19:20:00 -0500

si-local-file:///var/storage/secattach/20241114/23989102.html

Form SC 13G/A BIOLASE, INC Filed by: Lind Global Fund II LP

Thu, 14 Nov 2024 19:20:00 -0500

si-local-file:///var/storage/secattach/20241114/23989102.html

Form SC 13G/A BIOLASE, INC Filed by: Anson Funds Management LP

Thu, 14 Nov 2024 17:39:00 -0500

si-local-file:///var/storage/secattach/20241114/23988632.html

Form SC 13G/A BIOLASE, INC Filed by: Anson Funds Management LP

Thu, 14 Nov 2024 17:39:00 -0500

si-local-file:///var/storage/secattach/20241114/23988632.html

Form SC 13G/A BIOLASE, INC Filed by: Anson Funds Management LP

Thu, 14 Nov 2024 17:39:00 -0500

si-local-file:///var/storage/secattach/20241114/23988632.html

Form 10-Q BIOLASE, INC For: Sep 30

Thu, 07 Nov 2024 16:55:00 -0500

si-local-file:///var/storage/secattach/20241107/23945281.html

Form 10-Q BIOLASE, INC For: Sep 30

Thu, 07 Nov 2024 16:55:00 -0500

si-local-file:///var/storage/secattach/20241107/23945281.html

Form 10-Q BIOLASE, INC For: Sep 30

Thu, 07 Nov 2024 16:55:00 -0500

si-local-file:///var/storage/secattach/20241107/23945281.html

Form 8-K BIOLASE, INC For: Oct 02

Tue, 08 Oct 2024 16:47:00 -0500

si-local-file:///var/storage/secattach/20241008/23816476.html

Form 8-K BIOLASE, INC For: Oct 02

Tue, 08 Oct 2024 16:47:00 -0500

si-local-file:///var/storage/secattach/20241008/23816476.html

Form 8-K BIOLASE, INC For: Oct 02

Tue, 08 Oct 2024 16:47:00 -0500

si-local-file:///var/storage/secattach/20241008/23816476.html

Benchmark comments on Biolase (BIOL) following chapter 11 filing

Wed, 02 Oct 2024 06:54:25 -0500

Benchmark analyst Bruce D. Jackson weighed in on Biolase (NASDAQ: BIOL) after the company announced Chapter 11 filing.

The analyst commented: "Last night BIOLASE announced it would begin voluntary Chapter 11 bankruptcy proceedings and will seek court approval to remain open for business to complete the sale of its assets to a proposed stalking horse, Sonendo (SONX:$0.05, NR). Sonendo is offering to pay $14 million in cash for substantially all of BIOLASE’s assets under court supervision in order to create a minimum price for the sale process and potentially attract other bidders. BIOLASE is seeking approval of at least $2.5 million

Biolase (BIOL) Files Voluntary Chapter 11

Tue, 01 Oct 2024 16:07:49 -0500

BIOLASE, Inc. (NASDAQ: BIOL) today announced that the Company and its direct domestic subsidiaries have voluntarily initiated Chapter 11 proceedings (the "Bankruptcy Petitions") in the United States Bankruptcy Court for the District of Delaware (the "Court"). BIOLASE will seek Court approval to continue operating during the proceedings and remains focused on providing its customers with its award-winning dental lasers and customer service.

The Company also announced today that it is pursuing a sale process under Section 363 of the Bankruptcy Code in conjunction with the filing. To this end, BIOLASE has entered into an asset purchase agreement with Sonendo Inc. ("Sonendo"),

Form 8-K BIOLASE, INC For: Sep 30

Tue, 01 Oct 2024 16:06:00 -0500

si-local-file:///var/storage/secattach/20241001/23787976.html

Form 8-K BIOLASE, INC For: Sep 30

Tue, 01 Oct 2024 16:06:00 -0500

si-local-file:///var/storage/secattach/20241001/23787976.html